Puzo Michael J sold 2,380 shares as Johnson & Johnson (JNJ)'s stock rose 6.85%. The hedge fund run by Phill Gross held 3.68 million shares of the major pharmaceuticals company at the end of 2017Q2, valued at $486.48M, down from 3.75M at the end of the previous reported quarter. Tortoise Investment Management LLC now owns 4,349 shares of the company's stock worth $575,000 after purchasing an additional 139 shares during the last quarter. The firm's revenue was up 10.3% on a year-over-year basis. sell-side analysts anticipate that Johnson & Johnson will post 7.28 earnings per share for the current year.
Johnson & Johnson (NYSE:JNJ)'s earnings per share has been growing at a 11.2 percent rate over the past 5 year when average revenue increase was noted as 2 percent. It has underperformed by 4.16% the S&P500. The company has a market cap of $376,059.06, a PE ratio of 19.60, a PEG ratio of 2.85 and a beta of 0.80. The stock increased 0.66% or $0.34 during the last trading session, reaching $51.95. About 3.70 million shares traded. Henry Schein, Inc. (NASDAQ:HSIC) has risen 4.05% since December 5, 2016 and is uptrending. It has underperformed by 3.98% the S&P500. Therefore 47% are positive. Ally Financial had 43 analyst reports since July 29, 2015 according to SRatingsIntel.
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter. The firm earned "Sector Perform" rating on Monday, August 3 by RBC Capital Markets. The rating was downgraded by Bank of America to "Neutral" on Friday, April 8. Credit Suisse Group set a $154.00 target price on shares of Johnson & Johnson and gave the company an "outperform" rating in a research note on Thursday, October 19th. Garrison Bradford Associate, a New York-based fund reported 3,700 shares. On Monday, July 10 the stock rating was maintained by RBC Capital Markets with "Buy". RBC Capital Markets has "Buy" rating and $13800 target. The research group ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Fiercebiotech.com and their article: "Johnson & Johnson's JLABS looks east as it lands in Shanghai" published on December 05, 2017 as well as Prnewswire.com's news article titled: "Bernstein Liebhard LLP Reports Talcum Powder Lawsuit Plaintiff Prevails ..." with publication date: December 04, 2017. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have given a buy rating to the company. Therefore 57% are positive. The stock of Johnson & Johnson (NYSE:JNJ) has "Sell" rating given on Wednesday, August 2 by BTIG Research. As per Tuesday, August 15, the company rating was maintained by Jefferies. HSBC upgraded Morgan Stanley (NYSE:MS) on Friday, September 15 to "Buy" rating. The stock is a Buy among 1 brokerage firms polled by Factset Research.
A number of research analysts have issued reports on JNJ shares. The firm has "Hold" rating given on Monday, September 25 by Citigroup.
Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings results on Tuesday, October 17th. It also increased its holding in Alcoa Corp by 440,317 shares in the quarter, for a total of 1.54M shares, and has risen its stake in Automatic Data Processing In (NASDAQ:ADP). The company reported $1.90 EPS for the quarter, topping analysts' consensus estimates of $1.80 by $0.10. The stock of Johnson & Johnson (NYSE:JNJ) has "Buy" rating given on Tuesday, September 22 by UBS. Investors of record on Tuesday, May 30th will be issued a $0.84 dividend. Its down 0.21, from 1.09 in 2017Q1. It worsened, as 50 investors sold JNJ shares while 878 reduced holdings. 105 funds opened positions while 667 raised stakes. The De Burlo Group Inc holds 56,575 shares with $7.48 million value, down from 60,800 last quarter. Lenox Wealth Advisors Inc. lifted its holdings in Johnson & Johnson by 0.6% in the 2nd quarter. The State Of Tennessee Treasury Department holds 263,348 shares with $22.01M value, up from 191,118 last quarter. California Pub Employees Retirement accumulated 6.56 million shares. Endurance Wealth Management stated it has 40,724 shares. Stratford Consulting LLC raised its stake in shares of Johnson & Johnson by 0.6% in the 2nd quarter. Harding Loevner LP purchased a new stake in shares of Johnson & Johnson in the 2nd quarter worth $106,000. Prelude Cap Mgmt Lc holds 0.01% or 469 shares in its portfolio. Mariner Wealth Lc owns 107,108 shares for 0.67% of their portfolio. Shaker Financial Services Llc, a Virginia-based fund reported 29,890 shares. Reik Limited Liability Corp invested in 0.71% or 16,017 shares. Trust Co. of Virginia VA raised its position in shares of Johnson & Johnson by 2.3% in the third quarter. Carroll Assocs Incorporated accumulated 85,307 shares or 1.36% of the stock.